Pages that link to "Q24658633"
Jump to navigation
Jump to search
The following pages link to Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer (Q24658633):
Displaying 31 items.
- Cholesterolomics: An update (Q36249577) (← links)
- The Role of Oxysterols in Human Cancer. (Q39243604) (← links)
- Obesity and Breast Cancer: Current Insights on the Role of Fatty Acids and Lipid Metabolism in Promoting Breast Cancer Growth and Progression (Q45000100) (← links)
- Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance (Q47105247) (← links)
- Transcriptional Regulation of T-Cell Lipid Metabolism: Implications for Plasma Membrane Lipid Rafts and T-Cell Function (Q47160173) (← links)
- Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy (Q47162938) (← links)
- The significance of cholesterol and its metabolite, 27-hydroxycholesterol in breast cancer (Q47944717) (← links)
- Expression of oxysterol pathway genes in oestrogen-positive breast carcinomas (Q48362604) (← links)
- Inhibition of FASN and ERα signalling during hyperglycaemia-induced matrix-specific EMT promotes breast cancer cell invasion via a caveolin-1-dependent mechanism. (Q50055518) (← links)
- Selective changes in cholesterol metabolite levels in plasma of breast cancer patients after tumor removal. (Q50069373) (← links)
- An update on oxysterol biochemistry: New discoveries in lipidomics. (Q50110601) (← links)
- Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer. (Q55479657) (← links)
- Statins: a role in breast cancer therapy? (Q57105348) (← links)
- Diabetes, obesity and breast cancer (Q57105986) (← links)
- The cancer-associated microprotein CASIMO1 controls cell proliferation and interacts with squalene epoxidase modulating lipid droplet formation (Q57204754) (← links)
- Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer (Q58765163) (← links)
- Comparative Transcriptomics Unravels Prodigiosin's Potential Cancer-Specific Activity Between Human Small Airway Epithelial Cells and Lung Adenocarcinoma Cells (Q60046465) (← links)
- Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours (Q60919172) (← links)
- 25-HC decreases the sensitivity of human gastric cancer cells to 5-fluorouracil and promotes cells invasion via the TLR2/NF-κB signaling pathway (Q61796400) (← links)
- Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment (Q61812327) (← links)
- Oxysterol research: a brief review (Q64039633) (← links)
- The clinicomolecular landscape of de novo versus relapsed stage IV metastatic breast cancer (Q89752541) (← links)
- RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype (Q90662697) (← links)
- Menstrual cycle associated changes in hormone-related gene expression in oestrogen receptor positive breast cancer (Q91388562) (← links)
- FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype (Q91535153) (← links)
- Lipoprotein Drug Delivery Vehicles for Cancer: Rationale and Reason (Q92051968) (← links)
- Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities (Q92052398) (← links)
- Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer (Q92667609) (← links)
- PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance (Q98463455) (← links)
- Regulation of cellular sterol homeostasis by the oxygen responsive noncoding RNA lincNORS (Q99594542) (← links)
- Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance (Q104101361) (← links)